[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338083-105":59,"doc-detail-338083-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","sexannodb-sex-specific-regulations-from-multi-omics-data","SexAnnoDB - Sex-specific regulations from multi-omics data","","SexAnnoDB addresses limited mechanistic understanding of how sex disparities regulate cancer biology and outcomes across molecular levels. It tackles the gap in existing sex-difference tissue resources by integrating multi-omics analyses and mapping sex-biased regulatory mechanisms across 27 cancer types. The study examines sex-biased ceRNA, RNA-binding protein-exon skipping events, TF-gene networks, and multiple sex-biased QTL layers including expression and methylation, plus therapeutic target gene identification. Results are organized into a dedicated search platform.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sexannodb-sex-specific-regulations-from-multi-omics-data/338083/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sexannodb-sex-specific-regulations-from-multi-omics-data/338083.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does SexAnnoDB aim to solve in cancer research?","Question",{"text":113,"@type":114},"It addresses limited mechanistic knowledge of how sex disparities regulate cancer by focusing on sex-biased molecules and regulatory networks.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which types of sex-biased regulatory analyses were included across cancer types?",{"text":118,"@type":114},"The work integrates sex-biased ceRNA networks, sex-biased RNA binding protein–exon skipping events, sex-biased TF–gene regulatory networks, and sex-biased QTL layers including expression, methylation, and splicing QTLs, plus therapeutic target gene identification.",{"name":120,"@type":111,"acceptedAnswer":121},"What key therapeutic target findings were reported?",{"text":122,"@type":114},"The analyses defined 126 sex-associated cancer therapeutic target genes, including a subset with sex bias at both mRNA and protein levels; S100A9 was highlighted as a target of multiple drugs and linked to transcriptional regulation and promoter methylation effects in specific patient groups.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338083,1790143446,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Yang et al. Biology of Sex Differences (2024) 15:64  \n[https://doi.org/10.1186/s13293-024-00638-8](https://doi.org/10.1186/s13293-024-00638-8)  \nBiology of Sex Differences  \nDATABASE Open Access  \nSexAnnoDB, a knowledgebase of sex-specific  regulations from multi-omics data of human cancers  \nMengyuan Yang 1*, Yuzhou Feng2,3, Jiajia Liu4, Hong Wang 1, Sijia Wu5, Weiling Zhao4, Pora Kim4* and Xiaobo Zhou4*  \nAbstract  \nBackground Sexual differences across molecular levels profoundly impact cancer biology and outcomes. Patient gender significantly influences drug responses, with divergent reactions between men and women to the same drugs. Despite databases on sex differences in human tissues, understanding regulations of sex disparities in cancer is limited. These resources lack detailed mechanistic studies on sex-biased molecules.  \nMethods In this study, we conducted a comprehensive examination of molecular distinctions and regulatory networks across 27 cancer types, delving into sex-biased effects. Our analyses encompassed sex-biased competitive endogenous RNA networks, regulatory networks involving sex-biased RNA binding protein-exon skipping events, sex-biased transcription factor-gene regulatory networks, as well as sex-biased expression quantitative trait loci, sex-biased expression quantitative trait methylation, sex-biased splicing quantitative trait loci, and the identification of sex-biased cancer therapeutic drug target genes. All findings from these analyses are accessible on SexAnnoDB ( [https://ccsm.uth.edu/SexAnnoDB/](https://ccsm.uth.edu/SexAnnoDB/)) .  \nResults From these analyses, we defined 126 cancer therapeutic target sex-associated genes. Among them, 9 genes showed sex-biased at both the mRNA and protein levels. Specifically, S100A9 was the target of five drugs, of which calcium has been approved by the FDA for the treatment of colon and rectal cancers. Transcription factor (TF)-gene regulatory network analysis suggested that four TFs in the SARC male group targeted S100A9 and upregulated the expression ofS100A9 in these patients. Promoter region methylation status was only associated with S100A9 expression in KIRP female patients. Hypermethylation inhibited S100A9 expression and was responsible for the downregulation ofS100A9 in these female patients.  \nConclusions Comprehensive network and association analyses indicated that the sex differences at the transcriptome level were partially the result of corresponding sex-biased epigenetic and genetic molecules. Overall, SexAnnoDB offers a discipline-specific search platform that could potentially assist basic experimental researchers or physicians in developing personalized treatment plans.  \n*Correspondence: Mengyuan Yang [mengyuanyang@zzu.edu.cn](mengyuanyang@zzu.edu.cn)[ ](mengyuanyang@zzu.edu.cn)Pora Kim [Pora.Kim@uth.tmc.edu](Pora.Kim@uth.tmc.edu)[ ](Pora.Kim@uth.tmc.edu)Xiaobo Zhou [Xiaobo.Zhou@uth.tmc.edu](Xiaobo.Zhou@uth.tmc.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http:","cbCaij6hTcDEfIlQ","https://ap.wps.com/l/cbCaij6hTcDEfIlQ","pdf",8761719,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Plain language summary\n# Highlights\n# Keywords","[{\"question\":\"What problem does SexAnnoDB aim to solve in cancer research?\",\"answer\":\"It addresses limited mechanistic knowledge of how sex disparities regulate cancer by focusing on sex-biased molecules and regulatory networks.\"},{\"question\":\"Which types of sex-biased regulatory analyses were included across cancer types?\",\"answer\":\"The work integrates sex-biased ceRNA networks, sex-biased RNA binding protein–exon skipping events, sex-biased TF–gene regulatory networks, and sex-biased QTL layers including expression, methylation, and splicing QTLs, plus therapeutic target gene identification.\"},{\"question\":\"What key therapeutic target findings were reported?\",\"answer\":\"The analyses defined 126 sex-associated cancer therapeutic target genes, including a subset with sex bias at both mRNA and protein levels; S100A9 was highlighted as a target of multiple drugs and linked to transcriptional regulation and promoter methylation effects in specific patient groups.\"}]","SexAnnoDB - Sex-specific regulations from multi-omics data | PDF",1790021890,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38d8123c680097adaf8eda6bacbc24e0.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/239803849174d9586231ec0b3d2dc99c.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8baddef630bbfe0ca40a3eab8619ca4.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/998254b0fd04a9d4ce5cfb42a78f3280.webp",980,1306]